NDC 68382-110 – Bromocriptine mesylate
Bromocriptine Mesylate 5 mg/1 · Capsule · Oral
Product NDC68382-110
Product details
- Brand name
- Bromocriptine mesylate
- Generic name
- Bromocriptine mesylate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA078899
- Marketed since
- January 23, 2009
- Listing expires
- December 31, 2027
- Pharmacologic class
- Ergot Derivative
Active ingredients
- Bromocriptine Mesylate 5 mg/1
Uses, dosage, side effects and warnings for Bromocriptine Mesylate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 68382-110-01 | 100 CAPSULE in 1 BOTTLE (68382-110-01) | Jan 23, 2009 |
| 68382-110-06 | 30 CAPSULE in 1 BOTTLE (68382-110-06) | Jan 23, 2009 |
Recalls mentioning this NDC
- D-0159-2026 Nov 26, 2025 · Class II
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules. - D-1491-2016 Sep 14, 2016 · Class II
Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of…
Other Bromocriptine Mesylate products
- 70954-951 Bromocriptine Mesylate 5 mg/1 · Capsule · ANI Pharmaceuticals, Inc.
- 0378-7096 Bromocriptine Mesylate 5 mg/1 · Capsule · Mylan Pharmaceuticals Inc.
- 65841-654 Bromocriptine Mesylate 5 mg/1 · Capsule · Zydus Lifesciences Limited
- 60687-931 Bromocriptine Mesylate 2.5 mg/1 · Tablet · American Health Packaging
- 70954-978 Bromocriptine Mesylate 2.5 mg/1 · Tablet · ANI Pharmaceuticals, Inc.
- 0574-0106 Bromocriptine Mesylate 2.5 mg/1 · Tablet · Padagis US LLC
- 70518-4628 Bromocriptine Mesylate 2.5 mg/1 · Tablet · REMEDYREPACK INC.
- 0781-5325 Bromocriptine Mesylate 2.5 mg/1 · Tablet · Sandoz Inc